Blog
About

  • Record: found
  • Abstract: not found
  • Article: not found

The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?

Arteriosclerosis, Thrombosis, and Vascular Biology

Up-Regulation, Time Factors, Risk Factors, Risk Assessment, Practice Guidelines as Topic, drug therapy, complications, blood, Inflammation, Incidence, Humans, prevention & control, mortality, etiology, Coronary Disease, therapeutic use, Cardiovascular Agents, metabolism, C-Reactive Protein, Biological Markers, Anti-Inflammatory Agents

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Related collections

      Author and article information

      Journal
      10.1161/ATVBAHA.108.168989
      18565847

      Comments

      Comment on this article